Stockreport

World Health Organization Recommends INN for Thymosin Beta 4 as "timbetasin"

REGENERX BIOPHARMS INC  (RGRX) 
NASDAQ:AMEX Investor Relations: regenerx.com/investors
PDF ROCKVILLE, Md., Sept. 6, 2018 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company fo [Read more]